Management of amyotrophic lateral sclerosis (ALS) by the family nurse practitioner: A timeline for anticipated referrals

Journal of the American Academy of Nurse Practitioners

Volumn 23, Issue 9, 2011, Pages 464-472

  Davis, Melanie ^a   Lou, Jau Shin ^b  

^a PACIFIC LUTHERAN UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Clinical practice guidelines; Collaboration; Family practice; Neurology; Neuromuscular; Nurse practitioners; Treatment

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; DISEASE COURSE; GENERAL PRACTICE; HUMAN; METHODOLOGY; NURSE PRACTITIONER; NURSING; PALLIATIVE THERAPY; PATIENT REFERRAL; PROGNOSIS; REVIEW; TIME;

AMYOTROPHIC LATERAL SCLEROSIS; DISEASE PROGRESSION; FAMILY PRACTICE; HUMANS; NURSE PRACTITIONERS; PALLIATIVE CARE; PROGNOSIS; REFERRAL AND CONSULTATION; TIME FACTORS;

EID: 80052644914     PISSN: 10412972     EISSN: 17457599     Source Type: Journal    
DOI: 10.1111/j.1745-7599.2011.00628.x     Document Type: Review

References (47)

1. Aguirre, T., Van Den Bosch, L., Goetschalckx, K., Tilkin, P., Mathijs, G., Cassiman, J. J., & Robberecht, W. (1998). Increased sensitivity of fibroblasts from amyotrophic lateral sclerosis patients to oxidative stress. Annals of Neurology, 43, 452-457.
2. ALS Association. (2007). Resources. Retrieved April 2, 2009, from.
3. American Academy of Family Physicians. (1988). Conditions of the nervous system. Recommended Curriculum Guidelines for Family Medicine Residents, Reprint No. 272.
4. Andersen, P. M., Borasio, G. D., Dengler, R., Hardiman, O., Kollewe, K., Leigh., Tonnk, B. (2007). Good practice in the management of amyotrophic lateral sclerosis: Clinical guidelines. An evidence-based review with good practice points. EALSC Working Group. Amyotrophic Lateral Sclerosis, 8, 195-213.
5. Armon, C. (2003). An evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis. Neuroepidemiology, 22, 217-228.
6. Bensimon, G., & Lacomblez, L. (1996). A confirmatory dose-ranging study of riluzole in ALS. ALS/Riluzole Study Group-II. Neurology, 47, S242-S250.
7. Berger, M. M, et al. (2000). Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS. Neurology, 54, 20-25.
8. Borasio, G. D., Shaw, P. J., Hardiman, O., Ludolph, A. C., Sales Luis, M. L., & Silani, V. (2001). Standards of palliative care for patients with amyotrophic lateral sclerosis: Results of a European survey. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 2, 159-164.
9. Brooks, B. R. (1994). El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Journal of Neurosciences, 124, 96-107.
10. Chio, A., Galletti, R., Finocchiaro, C., Righi, D., Ruffino, M. A., Calvo, A., et al. (2004). Percutaneous radiologic gastrostomy: A safe and effective method of nutritional tube placement in advanced ALS. Journal of Neurology Neurosurgery and Psychiatry, 75, 645-647.
11. Chio, A., Mora, G., Balzarino, C., & Mutani, R. (2004). Interdisciplinary ALS centers: Effect of survival and use of health services in a population-based survey. Neurology, 62 (Suppl. 5), S23.003, Abstract 268.
12. Chio, A., Gianmartino, B., Dossena1, M., Mutani, R., & Mora, G. (2005) Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain, 128(3), 472-476.
13. Cobble, M. (1998). Language impairment in motor neuron disease. Journal of Neurology and Science, 160(Suppl 1), S47-S52.
14. Fallat, R. J., Jewitt, B., Bass, M., Kamm, B., & Norris, F. H. (1979). F. spirometry in ALS. Archives of Neurology, 36, 74-80.
15. Genetics Home Reference page. (2007). Retrieved from condition = amyotrophiclateralsclerosis.
16. Gordon, P., Rowland, L., Younger, D., Sherman, W. H., Hays, A. P., Louis, E. D., Latov, N. (1997). Lymphoproliferative disorders and motor neuron disease: An update. Neurology, 48(6), 1671-1678.
17. Hammer, E. M., Hacker, S., Hautzinger, M., Meyer, T. D., & Kubler, A. (2008). Validity of the ALS-depression-inventory (ADI-12)-A new screening instrument for depressive disorders in patients with amyotrophic lateral sclerosis. Journal of Affective Disorders, 109, 213-219.
18. Hafezparast, M., Klocke, R., Ruhrberg, C., Marquardt, A., Ahmad-Annuar, A., Bowen, S., Fisher, E. M. C. (2003). Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science, 300:808-812.
19. Krizbai, I. H., Deli, M. H., Pestenacz, A., Siklose, L., Szabo, C. A., Andras, I., & Joo, F. (1998). Expression of glutamate receptors on cultured cerebral endothelial cells. Journal of Neuroscience and Research, 54, 814-819.
20. Leigh, P. N., Abrahams, S., Al-Chalabi, A., Ampong, M. A., Goldstein, L. H., Johnson, J., et al. (2003). The management of motor neuron disease. Journal of Neurology, Neurosurgery and Psychiatry, 70 (Suppl. 4), 32-47.
21. Li, T. M., Day, S. J., Alberman, E., & Swash, M. (1986). Differential diagnosis of motor neuron disease from other neurological conditions. Lancet, 2, 731-733.
22. Lou, J. S, Moore, D., Gordon, P. H., & Miller, R. for the Minocycline Study Group. (2009). Correlates of quality of life in ALS: Lessons learned from the minocycline study. Amyotrophic Lateral Sclerosis, 1471-180X.
23. Lou, J. S., Reeves, A., Benice, T., & Sexton, G. (2003). Fatigue and depression are associated with poor quality of life in ALS. Neurology, 60, 122-123.
24. Lomen-Hoerth, C., Anderson, T., & Miller, B. (2002). The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology, 59, 1077-1079.
25. Lomen-Hoerth, C., Murphy, J., Langmore, S., Kramer, J. H., Olney, R. K., & Miller, B. (2003). Are amyotrophic lateral sclerosis patients cognitively normal? Neurology, 60, 1094-1097.
26. Mathus-Vliegen, L. M. H., Louwerse, L. S., Merkus, M. P., Tytgat, G. N. S., & Vianney de Jong, J. M. P. (1994). PEG in patients with ALS and impaired pulmonary function. Gastrointestinal Endoscopy, 40, 463-469.
27. Mazzini, L., Corra, T., Zaccala, M., Mora, G., del Piano, M., & Galante, M. (1995). PEG and enteral nutrition in ALS. Neurology, 242, 695-698.
28. McCluskey, L., Casarett, D., & Siderowf, A. (2004). Breaking the news: A survey of ALS patients and their caregivers. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 5, 131-135.
29. Mendoza, M., Gelinas, D. F., Moore, D. H., & Miller, R. G. (2007). A comparison of maximal inspiratory pressure and forced vital capacity as potential criteria for initiating non-invasive ventilation in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis, 8(2), 106-111.
30. Miller, R. G., Rosenberg, J. A., Gelinas, D. F., Mitsumoto, H., Newman, D., Sufit, R., et al. (1999). Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review): Report of the Quality Standards Subcommittee of the American. Academy of Neurology: ALS Practice Parameters Task Force. Neurology, 52, 1311-1323.
31. Miller, R. G., Mitchell, J. D., Lyon, M., & Moore, D. H. 2008. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database of Systematic Reviews, Issue 1, art. no. CD001447. doi:.
32. Miller, R. G., Jackson, C. E., Kasarskis, E. J., England, J. D., Forshew, D., Johnston, W., Woolley, S. C. (2009). Practice parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review): Report of the quality standards subcommittee of the American Academy of Neurology. Neurology, 73(15), 1218-1226.
33. Murphy, J. (2004). Communication strategies of people with ALS and their partners. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 5, 121-126.
34. Muscular Dystrophy Association. (2009). ALS division. Retrieved April 2, 2009, from.
35. National Consensus Project for Quality Palliative Care. (2009). Clinical practice guidelines for quality palliative care (2nd ed.). Pittsburgh, PA. Retrieved from.
36. National Institutes of Neurological Disorders and Stroke. (April 2003). Amyotrophic lateral sclerosis fact sheet. NIH Publication No. 900-916. Retrieved September 2009 from.
37. Pinto, A., de Carvalho, M., Evangelist, T., Lopes, A., & Sales-Luis, L. (2003). Nocturnal pulse oximetry: A new approach to establish the appropriate time for non-invasive ventilation in ALS patients. Amyotrophic Lateral Sclerosis, 4(1), 31-35.
38. Rao, S. D., & Weiss, J. H. (2004). Excitotoxic and oxidative cross-talk between motor neurons and glia in ALS pathogenesis. Trends in Neuroscience, 27, 17-23.
39. Robertson, J., Doroudchi, M. M., Nguyen, M. D., Durham, H. D., Strong, M. J., Shaw, G., Mushynski, W.E. (2003). A neurotoxic peripherin splice variant in a mouse model of ALS. Journal of Cell Biology, 160, 939-949.
40. Rosenberg, P. A., Amin, S., & Leitner, M. (1992). Glutamate uptake disguises neurotoxic potency of glutamate agonists in cerebral cortex in dissociated cell culture. Journal of Neuroscience, 12 (1), 56-61.
41. Rowland, L. P., & Shneider, N. A. (2001). Amyotrophic lateral sclerosis. New England Journal of Medicine, 344, 1688-1700.
42. Schiffman, P. L., & Belsh, J. M. (1993). Pulmonary function at diagnosis of ALS. Rate of deterioration. Chest, 103, 508-513.
43. Spencer, P. S., Nunn, P. B., Hugon, J., Ludolph, A. C., Ross, S. M., Roy, D. N., & Robertson, R.C. (1987). Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science, 237, 517-522.
44. Weisskopf, M. G., O'Reilly, E. J., McCullough, M. L., Calle, E. E., Thun, M. J., Cudkowicz, M., & Ascherio, A. (2005). Prospective study of military service and mortality from amyotrophic lateral sclerosis. Neurology, 64(1), 32-37.
45. Wijesekera, L. C., & Leigh, P. N. (2009). Amyotrophic lateral sclerosis. Orphanet Journal of Rare Diseases, 4, 4-3. 3:.
46. Wong, N. K., He, B. P., & Strong, M. J. (2000). Characterization of neuronal intermediate filament protein expression in cervical spinal motor neurons in sporadic amyotrophic lateral sclerosis (ALS). Journal of Neuropathology & Experimental Neurology, 59(11), 972-982.
47. Zhao, W., Beers, D. R., Henkel, J. S., Zhang, W., Urushitani, M., Julien, J. P., & Appel, S.H. (2010). Extracellular mutant SOD1 induces microglial-mediated motoneuron injury. Glia, 58(2), 231-243.